Future perspective of targeted treatments in pediatric low-grade glioma (pLGG): the evolution of standard-of-care and challenges of a new era-Reference-Cited by-同舟云学术

Future perspective of targeted treatments in pediatric low-grade glioma (pLGG): the evolution of standard-of-care and challenges of a new era

Published:2024-07-31 Issue: Volume: Page:
ISSN:0256-7040
Container-title:Child's Nervous System
language:en
Short-container-title:Childs Nerv Syst

Author:

Plant-Fox Ashley S.,Tabori Uri

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00381-024-06504-7.pdf

Reference80 articles.

1. Krishnatry R, Zhukova N, Guerreiro Stucklin AS et al (2016) Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: a population based study. Cancer 122(8):1261–9

2. Ryall S, Zapotocky M, Kukuoka K et al (2020) Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 37(4):583.e5

3. Wisoff JH, Sanford RA, Heier LA et al (2011) Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study form the Children’s Oncology Group. Neurosurgery 68(6):1548–54

4. de Blank PMK, Lange KR, Xing M et al. (2024) Temporal changes in treatment and late mortality and morbidity in adult survivors of childhood glioma: a report from the Childhood Cancer Survivor Study. Nat Cancer. Online ahead of print

5. Meadows AT, Gordon J, Massari DJ et al (1981) Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukemia treated with cranial irradiation. Lancet 2(8254):1015–8

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The tumorigenic effect of the high expression of ABRACL in glioma and its potential as a therapeutic target;Heliyon;2024-09